- Home
- ATAI vs JPI Comparison
ATAI vs JPI Comparison
Compare ATAI & JPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATAI
- JPI
- Stock Information
- Founded
- ATAI 2018
- JPI 2012
- Country
- ATAI Germany
- JPI United States
- Employees
- ATAI N/A
- JPI N/A
- Industry
- ATAI Biotechnology: Pharmaceutical Preparations
- JPI Finance Companies
- Sector
- ATAI Health Care
- JPI Finance
- Exchange
- ATAI Nasdaq
- JPI Nasdaq
- Market Cap
- ATAI 271.6M
- JPI 278.6M
- IPO Year
- ATAI 2021
- JPI N/A
- Fundamental
- Price
- ATAI $1.45
- JPI $19.72
- Analyst Decision
- ATAI Strong Buy
- JPI
- Analyst Count
- ATAI 4
- JPI 0
- Target Price
- ATAI $9.00
- JPI N/A
- AVG Volume (30 Days)
- ATAI 2.1M
- JPI 54.7K
- Earning Date
- ATAI 03-17-2025
- JPI 01-01-0001
- Dividend Yield
- ATAI N/A
- JPI 6.15%
- EPS Growth
- ATAI N/A
- JPI N/A
- EPS
- ATAI N/A
- JPI N/A
- Revenue
- ATAI $308,000.00
- JPI N/A
- Revenue This Year
- ATAI N/A
- JPI N/A
- Revenue Next Year
- ATAI $20.00
- JPI N/A
- P/E Ratio
- ATAI N/A
- JPI N/A
- Revenue Growth
- ATAI N/A
- JPI N/A
- 52 Week Low
- ATAI $0.78
- JPI $16.02
- 52 Week High
- ATAI $2.85
- JPI $19.12
- Technical
- Relative Strength Index (RSI)
- ATAI 43.24
- JPI 45.79
- Support Level
- ATAI $1.33
- JPI $19.34
- Resistance Level
- ATAI $1.48
- JPI $19.79
- Average True Range (ATR)
- ATAI 0.11
- JPI 0.20
- MACD
- ATAI -0.01
- JPI 0.00
- Stochastic Oscillator
- ATAI 43.41
- JPI 36.19
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.
About JPI Nuveen Preferred and Income Term Fund of Beneficial Interest
Nuveen Preferred and Income Term Fund is a closed-end management investment company. Its investment objective is to provide a high level of current income and total return. The company's products include mutual funds, closed-end funds, Exchange-traded funds, Multi-asset model portfolios, and others.